Inventor · disambiguated record
Mitchell H. Finer
Also filed as: FINER MITCHELL · FINER MITCHELL H · FINER MITCHELL HOWARD
21 granted patents·12 pending applications·674 citations·filing 1993–2023
96Inventor score
Files withCELL GENESYS INC12ONCORUS INC8CODA BIOTHERAPEUTICS INC3VIROGIN BIOTECH CANADA LTD3BLUEBIRD BIO INC2
Top patents by PatentIndex Score
33 records- 0195US5686279AMethod for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1994·Granted Nov 11, 1997·151 cites·18 claims
- 0293US5872005APackaging cell lines for adeno-associated viral vectorsCELL GENESYS INC·Filed 1995·Granted Feb 16, 1999·143 cites·15 claims
- 0393US5858740AMethod for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1995·Granted Jan 12, 1999·91 cites·50 claims
- 0492US6506604B2Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 2001·Granted Jan 14, 2003·32 cites·22 claims
- 0592US5834256AMethod for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1993·Granted Nov 10, 1998·104 cites·99 claims
- 0690US12208126B2Oncolytic viral vectors and uses thereofVIROGIN BIOTECH CANADA LTD·Filed 2023·Granted Jan 28, 2025·1 cites·23 claims
- 0789US6521602B1Anti-neoplastic compositions and uses thereofGPC BIOTECH INC·Filed 2000·Granted Feb 18, 2003·22 cites·11 claims
- 0886US7252991B2Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 2002·Granted Aug 7, 2007·11 cites·1 claims
- 0985US10391132B2Oncolytic viral vectors and uses thereofONCORUS INC·Filed 2018·Granted Aug 27, 2019·3 cites·25 claims
- 1084US9061031B2Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathyBLUEBIRD BIO INC·Filed 2014·Granted Jun 23, 2015·10 cites·21 claims
- 1183US11452750B2Oncolytic viral vectors and uses thereofONCORUS INC·Filed 2019·Granted Sep 27, 2022·2 cites·31 claims
- 1282US11078280B2Oncolytic viral delivery of therapeutic polypeptidesONCORUS INC·Filed 2020·Granted Aug 3, 2021·1 cites·13 claims
- 1382US8858928B2Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathyDENARO MARIA JOANN·Filed 2012·Granted Oct 14, 2014·9 cites·18 claims
- 1481US7083971B1Hybrid yeast-bacteria cloning system and uses thereofCELL GENESYS INC·Filed 2000·Granted Aug 1, 2006·8 cites·2 claims
- 1580US6218187B1Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1999·Granted Apr 17, 2001·42 cites·51 claims
- 1677US6051427AMethod for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1995·Granted Apr 18, 2000·31 cites·13 claims
- 1776US2024207334A1Oncolytic viral delivery of therapeutic polypeptidesVIROGIN BIOTECH CANADA LTD·Filed 2023·Application pending·0 cites
- 1874US2023115116A1Oncolytic viral vectors and uses thereofONCORUS INC·Filed 2022·Application pending·0 cites
- 1972US11612625B2Oncolytic viral vectors and uses thereofONCORUS INC·Filed 2018·Granted Mar 28, 2023·1 cites·26 claims
- 2067US11865081B2Oncolytic viral delivery of therapeutic polypeptidesVIROGIN BIOTECH CANADA LTD·Filed 2018·Granted Jan 9, 2024·0 cites·14 claims
- 2155US6797505B2Recombinant AAV vectors for gene therapy of hemophilia ACELL GENESYS INC·Filed 1998·Granted Sep 28, 2004·10 cites·20 claims
- 2253US2015329640A1Chimeric antigen receptors and immune cells targeting b cell malignanciesBLUEBIRD BIO INC·Filed 2013·Application pending·0 cites
- 2351US2023332182A1Compositions and methods for cellular reprogramming using circular rnaELEVATEBIO TECH INC·Filed 2021·Application pending·0 cites
- 2450US2022117902A1Encapsulated rna polynucleotides and methods of useONCORUS INC·Filed 2020·Application pending·0 cites
- 2549US9789139B2Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathyDENARO MARIA JOANN·Filed 2012·Granted Oct 17, 2017·0 cites·14 claims
- 2649US2004092008A1Recombinant AAV vectors for gene therapy of hemophilia AFiled 2002·Application pending·0 cites
- 2748US2021403950A1Encapsulated polynucleotides and methods of useONCORUS INC·Filed 2019·Application pending·0 cites
- 2846US2002168342A1Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methodsCELL GENESYS INC·Filed 2001·Application pending·0 cites
- 2942US2020224220A1Encapsulated polynucleotides and methods of useONCORUS INC·Filed 2018·Application pending·0 cites
- 3040US6413943B1Methods and reagents for inhibiting proliferation of smooth muscle cellsCELL GENESYS INC·Filed 1999·Granted Jul 2, 2002·2 cites·26 claims
- 3140US2018193414A1Compositions and methods for treating neurological disordersCODA BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3240US2018258424A1Crispr compositions and methods of using the same for gene therapyCODA BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3334US2018148711A1Genome editing vectorsCODA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mitchell H. Finer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →